Sanofi Ventures β Full Portfolio
107 tracked investments Β· listed companies and verified rows first
BiotechSan Diego, US
Amir Nashat(Director)John Mendlein(Director)Christian Weyer(Executive Officer, Director)William Rastetter(Director)J. Scott Wolchko(Executive Officer)Mark Enyedy(Director)
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications.
BiotechMedical Devices
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Jonathan Root(Director)Casper De Clercq(Director)Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)Sean Duffy(Executive Officer, Director)Balaji Srinivasan(Director)
Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Ryan Berry(Director)Donald McCarthy(Director)John Edwards(Director)Yajun Xu(Director)
Board seatJason P. HaflerΒ· per SEC Form D
Granite Bio develops first-in-class therapeutic antibodies targeting inflammation, autoimmunity, and fibrosis for patients lacking effective treatment options.
BiotechMedical DevicesBasel, CH
Patrick Loustau(President and Chief Executive Officer)
Lifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization.
BiotechDeep TechHealthtech
Arthur O. Tzianabos, Ph.D.(President and CEO)Naina Bhasin, Ph.D.(Chief Business Officer)
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Frutos(Co-founder)Dr. Vila-PerellΓ³(CEO)
AdvanCell develops radioisotope-based therapies, using Th-228 sourced through the U.S.
BiotechHealthtechMedical DevicesCambridge, US
Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)Wing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)Jamil Beg(Director)
Board seatChristopher GagliardiΒ· per SEC Form D
Click Therapeutics develops software-based prescription medical treatments for patients with unmet medical needs, combining neuroscience with digital technology to create a new treatment modality.
Digital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)Nicholas Schork(Director)Victor Gao(Director)Emile Westergaard(Director)
BoardAlex Zisson(Director)
Board seatCris De LucaΒ· per SEC Form D
BiotechSan Diego, US
JeenJoo Kang(Director)Robert Tjian(Director)Alain Baron(Executive Officer, Director)Marcus Boehm(Executive Officer)Andrew Schwab(Director)
Board seatJason P. HaflerΒ· per SEC Form D Β· $77.5M raise Β· filed Sep 2020
BiotechDel Mar, US
Paul Stone(Executive Officer)Yujiro Hata(Director)Kevin Forrest(Executive Officer, Director)Scott Rocklage(Executive Officer, Director)Matthew Disney(Director)Jason Hafler(Director)
Board seatJason P. HaflerΒ· per SEC Form D Β· $5M raise Β· filed Jun 2017
Cambridge, US
Board seatJason P. HaflerΒ· per SEC Form D Β· $70M raise Β· filed Oct 2022
South San Francisco, US
Board seatJason P. HaflerΒ· per SEC Form D Β· $125M raise Β· filed Oct 2025
Atalanta is a mathematical AI company that provides software verification and formal methods capabilities to ensure provably correct decision-making in complex systems for high-stakes missions in energy, space, and defense sectors.
AI & Machine LearningDeep TechDefense Tech
Attovia develops precision biologics using its ATTOBODY platform for patients with immune-mediated diseases.
BiotechDigital Health
Avilar develops protein degrader drugs targeting extracellular and membrane-bound proteins, using a novel class called ATACs that harness endolysosomal degradation machinery.
AI & Machine LearningBiotechMedical DevicesWaltham, US
THERESA CAMERON(Director)PAULINA HILL(Director)MARTIN FREED(Director)STEPHANIE TOZZO(Executive Officer)PHIL GRAHAM(Executive Officer)MILIND DESHPANDE(Director)
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical Devices
David Meek(Chief Executive Officer)Brian Riley(President & Chief Technical Officer)Joanne Lager(Chief Medical Officer)Wendy DiCicco(Chief Financial Officer)Adrian Chaisson(Chief of Staff)Daniel S. Lynch(Director)
BranchLab is a healthcare AI company that builds predictive systems for regulated organizations in the healthcare sector, helping them make better decisions about patient outcomes and treatment commercialization while maintaining privacy and regulatory compliance.
AI & Machine LearningHealthtechNew York, US
Michael Parkes(Director)Joshua Walsh(Executive Officer, Director)Carrie Williams(Director)Christopher Cagle(Executive Officer, Director)
BoardAndrew Bouldin(Director)
Carbon Health operates a chain of clinics and a companion app offering primary, urgent, and virtual care visits, with same-day appointments, provider chat, and access to medical records.
Digital HealthHealthtech
Eren Bali(Founder)
HealthtechCambridge, US
Richard Whalley(Executive Officer, Director)Patrick Flynn(Director)James White(Executive Officer, Director)
Manhattan Beach, US
Peter Kim(Executive Officer, Director, Promoter)Francis Lam(Executive Officer, Director, Promoter)Bill Geary(Director)Mohamad Makhzoumi(Director)
Empatica develops software and algorithms that monitor neurological patients through wearable sensors, providing real-time physiological and behavioral biomarkers to patients, clinicians, and researchers.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCambridge, US
Rosalind Picard(Founder and Director of the Affective Computing Group at the MIT Media Lab and Faculty Chair, MIT Mind+Hand+Heart Wellbeing Initiative)Matteo Lai(Executive Officer, Director)Mario Scuderi(Director)Simone Tognetti(Director)
Company measuring health in everyday life via a permissioned real-world data platform.
Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.
BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US
David Fleshman(Director)Rowan Chapman(Director)Christine Lemke(Executive Officer, Director)Deborah Kilpatrick(Executive Officer, Director)
Developing therapies for congenital disorders of glycosylation combining replacement therapies with intracellular delivery vehicles.
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
Biotech
Steven Axon(Chief Executive Officer)Hicham Alaoui(Chief Scientific Officer)Rose Marino(Chief Medical Officer)Peter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)
Sebastian G. Schneeweiss(Director)William Geary(Director)Jeremy Rassen(Executive Officer, Director)
Biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections using ionic liquid technology
BiotechSaratoga, US
Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)
BiotechSeattle, US
Peter Kolchinsky(Director)Charles Richardson(Senior Vice President, Technical Operations)Mark McDade(Director)Terry Gould(Director)Adam K. Simpson(President and Chief Executive Officer)Eric Moessinger(Director)
Privately-held biotech company developing biologic therapies for retinal diseases
BiotechBoston, US
Zach Scheiner(Director)William Daley Bonificio(Executive Officer, Promoter)Megan Krench(Director)Stephen Basil Thomas(Executive Officer, Promoter)Dmitrij Hristodorov(Director)Naveen Manu Daryani(Executive Officer, Director, Promoter)
Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach.
AI & Machine LearningHealthtechMedical DevicesSan Diego, US
Paul Berns(Director)Joseph Papa(Director)Mark C. McKenna(Executive Officer, Director)Scott Glenn(Director)Kristina Burow(Director)Vika Brough(Executive Officer)
BiotechCambridge, US
Jean-Francois Formela(Director)Rick Lundberg(Executive Officer)Alan Crane(Director)David Madden(Director)Marian Nakada(Director)Brian Gallagher(Director)
NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients.
BiotechDigital HealthMedical DevicesAustin, US
Detlev Biniszkiewicz(Director)Ivan Cheung(Executive Officer, Director)Axel Hoos(Director)R. Jacob Vogelstein(Director)Brian Shuster(Director)Paulina Hill(Director)
Biotech company founded by Dame Carol Robinson building on native mass spectrometry for small molecule drug discovery.
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Laia Crespo-Martin(Director)Shafique Virani(Executive Officer)Johannes Fruehauf(Director)
Science 37 operates a direct-to-patient clinical trial site that brings clinical research to patients' homes through trained nurses and coordinators, eliminating geographic and accessibility barriers to trial participation.
HealthtechMedical Devices
Trial Library is an AI-native platform that integrates clinical trials into routine healthcare by connecting patients, providers, payers, and pharmaceutical sponsors.
AI & Machine LearningDigital HealthHealthtech
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.